Akari Therapeutics (AKTX) Return on Capital Employed Growth (1y) (2016 - 2026)
Akari Therapeutics (AKTX) Return on Capital Employed Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,914.07 Bn | 1,914.01 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 469.68 Bn | 464.89 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 122.76 Bn | 115.51 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 70.40 Bn | 61.65 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.88 Bn | 50.69 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn | 2,400.00 |
| 10 | Revolution Medicines | 37.17 Bn | 37.17 Bn | - | -3,457.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31,429.00 |
| Dec 31, 2025 | 185,449.00 |
| Sep 30, 2025 | -77,536.00 |
| Jun 30, 2025 | -79,293.00 |
| Mar 31, 2025 | -108,078.00 |
| Jun 30, 2018 | -10,317.00 |
| Jun 30, 2017 | 1,287.00 |
| Jun 30, 2016 | 7,012.00 |
| Mar 31, 2016 | 11,445.00 |